Svmuu News, Greeks.live posted on platform X stating that tomorrow will see the largest options expiry of the first quarter this year, with nearly 40% of options facing expiration.
1. Core Expiry Data: BTC Max Pain: Currently anchored at $75,000, which seems unattainable given the current situation. Put/Call Ratio (P/C Ratio): Remains around 0.6, relatively low, indicating lower trading volume for put options, but overall market sentiment remains bearish.
2. Volatility (IV) Warning: An IV Crush is imminent. The front-end implied volatility (Front-end IV) near the expiration date remains firm. However, once the expiry concludes tomorrow, a sharp IV Crush (volatility plummet) is highly likely. Currently, buyers of short-term options are at a significant disadvantage (severe Theta decay), while sellers hold a clear advantage.
3. Whales and Block Trades: Today's block trade data on Deribit shows that Smart Money is aggressively engaging in rolling operations. Many institutions have closed their positions expiring tomorrow and are heavily establishing positions in out-of-the-money call options (OTM Calls) for June and September.
Greeks.live: Tomorrow Will See the Largest Options Expiry of Q1, Nearly 40% of Options Face Expiration
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
4
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
7
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










